We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Quotient Sciences Acquires Pharmaterials, a UK-based Contract Development and Manufacturing Organization

News   Nov 18, 2017

 
Quotient Sciences Acquires Pharmaterials, a UK-based Contract Development and Manufacturing Organization
 
 
 

RELATED ARTICLES

Ketone Shuttle Coordinates Response to Liver Fibrosis

News

A metabolite shuttle, or dialogue, provides a connection between hepatocyte and macrophage cell types in the liver and helps protect against tissue fibrosis.

READ MORE

Anti-Malaria Drugs Show Promise in Treating Cancer – Now We Know Why

News

Anti-malaria drugs known as chloroquines have been repurposed to treat cancer for decades, but until now no one knew exactly what the chloroquines were targeting when they attack a tumor. Now, researchers say they have identified that target - an enzyme called PPT1 - opening up a new pathway for potential cancer treatments.

READ MORE

Reflecting on Norovirus Outbreaks May Help Guide Vaccine Development

News

Study confirms several factors that can make norovirus outbreaks more severe and may help guide efforts to develop a vaccine to prevent this highly contagious disease.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma Cell Science Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE